SAIPARENT521.00

Sai Parenterals Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersINDOCOPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,302 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Revenue from Operations381.0
Other Income8.5
Total Income389.5
Expenses
+ Cost of Materials Consumed238.1
+ Changes in Inventories4.1
+ Employee Benefit Expense29.3
+ Finance Costs18.4
+ Depreciation & Amortisation16.9
+ Other Expenses70.8
Total Expenses377.6
EBITDA38.7
EBIT21.8
Profit
PBT before Exceptional Items11.9
Pretax Income11.9
+ Current Tax4.9
+ Deferred Tax-7.3
Tax Expense-2.3
Net Income14.3
+ Net Income — Continuing Ops14.3
+ Other Comprehensive Income0.1
Total Comprehensive Income14.4
Per Share
Basic EPS4.36
Diluted EPS4.36
Other Comprehensive Income — detail
+ Other Comprehensive Income0.1
+ Items NOT to be Reclassified to P&L0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations4.36
Diluted EPS — Continuing Operations4.36
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit138.8
Gross Margin %36.42
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)11.9
Net Income Adj (tax-effected)14.3
EPS Adj4.36
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value5.00
Paid Up Equity Capital22.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.